AKRO — Akero Therapeutics Share News
0.000.00%
Last trade - 00:00Akero Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Akero Therapeutics Q2 net income just shy of estimates, cash position strong
Brief: Pfizer Dissolves Share Stake In Akero Therapeutics
Akero Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Akero Therapeutics Q1 Operating Expenses USD 80.9 Million
Akero Therapeutics Inc expected to post a loss of 97 cents a share - Earnings Preview
Brief: Akero Therapeutics Announces Upcoming Poster And Oral Presentations At The Easl Congress 2025
Akero Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
U.S. STOCKS ON THE MOVE-Signing Day Sports, Merchants Bancorp, Stride
U.S. STOCKS ON THE MOVE-89Bio, Brinker, Apple
89bio rises after $250 mln equity haul
Akero Therapeutics gains after upsized $350 mln equity raise
Brief: Akero Therapeutics Announces Pricing Of Upsized Public Offering Of Common Stock And Pre-Funded Warrants
U.S. RESEARCH ROUNDUP-Akero Therapeutics, Coca-Cola, Mastec
89bio slides on stock offering to fund MASH drug
U.S. STOCKS ON THE MOVE-Middleby, Boeing, Aurora Mobile
U.S. STOCKS ON THE MOVE-Sagimet Biosciences, Sage Therapeutics, Qorvo
U.S. STOCKS ON THE MOVE-Tevogen Bio, Akero Therapeutics, AspenTech
Akero shares double after preliminary results from mid-stage trial for liver disease drug (updated)